A Two-Stage, Open-Label Followed by Placebo-C

Project: Research project

Project Details

Description

A Two-Stage, Open-Label Followed by Placebo-Controlled Phase 2 Study of Pracinostat and Azacitidine in Patients with IPSS-R High and Very High Risk Myelodysplastic Syndromes Previously Untreated with Hypomethylating Agents
StatusActive
Effective start/end date10/1/172/28/21

Funding

  • MEI PHARMA, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.